Aortic stenosis is a type of heart valve disease that becomes more common with age, affecting 1 in 10 people over the age of 75.
Time to Act: What You Need to Know About Medicare’s Proposed TAVR Decision and How to Lend Your Voice to Make a Difference
1-2:00 PM ET
On March 26, the Centers for Medicare & Medicaid Services (CMS) released its updated proposed decision on Medicare coverage for a less-invasive heart valve disease treatment called transcatheter aortic valve replacement (TAVR).
Unfortunately, the update continues to base patient access on hospitals’ procedural volume ahead of equal access and quality care for patients. The extensive data from seven years of TAVR procedures shows that there is no longer a relationship between volume and health outcomes.
Join the Alliance for Aging Research and Heart Valve Voice US for a webinar that will walk you through the proposed decision and show you how to submit comments to CMS and ensure that the amended TAVR coverage decision will be of most benefit to all patients.
The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.
The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.